The Experts below are selected from a list of 276 Experts worldwide ranked by ideXlab platform
Frederic H. Fahey - One of the best experts on this subject based on the ideXlab platform.
-
Image Gently in Nuclear Medicine at Ten Years
2019Co-Authors: Frederic H. Fahey, S. Ted Treves, Marilyn Goske, Michael J. Gelfand, Marguerite T. Parisi, Michael Lassmann, Briana Sexton-stalloneAbstract:Poster: "EuroSafe Imaging 2019 / ESI-0058 / Image Gently in Nuclear Medicine at Ten Years" by: "F. Fahey1, S. T. Treves2, M. Goske1, M. Gelfand3, M. Parisi4, M. Lassmann5, B. Sexton-Stallone1; 1Image Gently Alliance Nuclear Medicine Working Group Boston/US, 2Image Gently Aliiance Nuclear Medicine Working Group Boston/US, 3Image Gently Alliance Nuclear Medicine Working Group Cincinnati/US, 4Image Gently Alliance Nuclear Medicine Working Group Seattle/US, 5Image Gently Alliance Nuclear Medicine Working Group Wurzburg/DE"
-
dose estimation in pediatric Nuclear Medicine
Seminars in Nuclear Medicine, 2017Co-Authors: Frederic H. Fahey, Alison Goodkind, Donika Plyku, Kitiwat Khamwan, Shannon Oreilly, Xinhua Cao, Eric C Frey, Wesley E BolchAbstract:The practice of Nuclear Medicine in children is well established for imaging practically all physiologic systems but particularly in the fields of oncology, neurology, urology, and orthopedics. Pediatric Nuclear Medicine yields images of physiologic and molecular processes that can provide essential diagnostic information to the clinician. However, Nuclear Medicine involves the administration of radiopharmaceuticals that expose the patient to ionizing radiation and children are thought to be at a higher risk for adverse effects from radiation exposure than adults. Therefore it may be considered prudent to take extra care to optimize the radiation dose associated with pediatric Nuclear Medicine. This requires a solid understanding of the dosimetry associated with the administration of radiopharmaceuticals in children. Models for estimating the internal radiation dose from radiopharmaceuticals have been developed by the Medical Internal Radiation Dosimetry Committee of the Society of Nuclear Medicine and Molecular Imaging and other groups. But to use these models accurately in children, better pharmacokinetic data for the radiopharmaceuticals and anatomical models specifically for children need to be developed. The use of CT in the context of hybrid imaging has also increased significantly in the past 15 years, and thus CT dosimetry as it applies to children needs to be better understood. The concept of effective dose has been used to compare different practices involving radiation on a dosimetric level, but this approach may not be appropriate when applied to a population of children of different ages as the radiosensitivity weights utilized in the calculation of effective dose are not specific to children and may vary as a function of age on an organ-by-organ bias. As these gaps in knowledge of dosimetry and radiation risk as they apply to children are filled, more accurate models can be developed that allow for better approaches to dose optimization. In turn, this will lead to an overall improvement in the practice of pediatric Nuclear Medicine by providing excellent diagnostic image quality at the lowest radiation dose possible.
-
Quality and Safety in Nuclear Medicine: The Vision of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)
Quality in Nuclear Medicine, 2016Co-Authors: Bennett S. Greenspan, Frederic H. Fahey, George M. SegallAbstract:The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is a nonprofit, professional, and scientific organization that promotes the science, technology, and practical application of Nuclear Medicine and molecular imaging. The SNMMI is a leader in advancing, optimizing, and unifying Nuclear Medicine/molecular imaging, with the ultimate goal of improving human health. It has over 17,000 members worldwide, the majority of which are in the USA. The SNMMI is based in Reston, Virginia, USA.
-
Nuclear Medicine and Radiation Protection
Journal of Radiology Nursing, 2016Co-Authors: Frederic H. Fahey, Alison Goodkind, S. Ted Treves, Frederick D. GrantAbstract:Abstract Nuclear Medicine and molecular imaging procedures play an important role in the diagnosis, assessment, and treatment of many diseases. These include diseases of the heart, skeleton, brain, and kidneys as well as applications in oncology. The following article discusses various Nuclear Medicine diagnostic and therapeutic applications, and the technology behind them. Finally, radiation safety in the context of Nuclear Medicine will be discussed. It is important that all members of the Nuclear Medicine team are equipped to provide an appropriate discussion of the benefits and risks of Nuclear Medicine to our patients and their families.
-
minimizing and communicating radiation risk in pediatric Nuclear Medicine
The Journal of Nuclear Medicine, 2012Co-Authors: Frederic H. Fahey, Ted S Treves, James S AdelsteinAbstract:The value of pediatric Nuclear Medicine is well established. Pediatric patients are referred to Nuclear Medicine from nearly all pediatric specialties including urology, oncology, cardiology, gastroenterology, and orthopedics. Radiation exposure is associated with a potential, small, risk of inducing cancer in the patient later in life and is higher in younger patients. Recently, there has been enhanced interest in exposure to radiation from medical imaging. Thus, it is incumbent on practitioners of pediatric Nuclear Medicine to have an understanding of dosimetry and radiation risk to communicate effectively with their patients and their families. This article reviews radiation dosimetry for radiopharmaceuticals and also CT given the recent proliferation of PET/CT and SPECT/CT. It also describes the scientific basis for radiation risk estimation in the context of pediatric Nuclear Medicine. Approaches for effective communication of risk to patients' families are discussed. Lastly, radiation dose reduction in pediatric Nuclear Medicine is explicated.
Habib Zaidi - One of the best experts on this subject based on the ideXlab platform.
-
Quantitative Analysis in Nuclear Medicine Imaging - Quantitative Analysis in Nuclear Medicine Imaging
Journal of Nuclear Medicine, 2007Co-Authors: Habib ZaidiAbstract:Quantitative Analysis in Nuclear Medicine Imaging is an in-depth review of single-photon and PET Nuclear Medicine image reconstruction, correction, modeling, and analysis techniques, with a particular emphasis on quantitative imaging for both diagnostic and therapeutic (i.e., internal radionuclide
-
quantitative analysis in Nuclear Medicine imaging
The Journal of Nuclear Medicine, 2006Co-Authors: Habib ZaidiAbstract:Quantitative Analysis in Nuclear Medicine Imaging is an in-depth review of single-photon and PET Nuclear Medicine image reconstruction, correction, modeling, and analysis techniques, with a particular emphasis on quantitative imaging for both diagnostic and therapeutic (i.e., internal radionuclide
Michael M. Graham - One of the best experts on this subject based on the ideXlab platform.
-
the future of Nuclear Medicine molecular imaging and theranostics
The Journal of Nuclear Medicine, 2020Co-Authors: Wolfgang A Weber, Johannes Czernin, Carolyn J Anderson, Ramsey D Badawi, Henryk Barthel, Frank M Bengel, Lisa Bodei, Irene Buvat, Marcelo F Dicarli, Michael M. GrahamAbstract:### Wolfgang A. Weber and Johannes Czernin Scientific discoveries published in The Journal of Nuclear Medicine over the past 60 years have shaped the practice of Medicine and form the foundation for the future of Nuclear Medicine, molecular imaging, and theranostics. Nuclear Medicine now provides
-
The Nuclear Medicine job market
The Journal of Nuclear Medicine, 2006Co-Authors: Benjamin L. Franc, Heather A. Jacene, Sibyll Goetze, Lynn Barnes, Michael M. GrahamAbstract:1012 Objectives: Nuclear Medicine continues to expand and the advent of combined modality imaging requires Nuclear Medicine physicians to be versed in both functional and anatomic imaging. This has led to increased concern regarding job availability for physicians trained only in Nuclear Medicine, but limited data on this topic exists. Our objective was to gain a better understanding of the current state of the job market for Nuclear Medicine physicians. Methods: A 28 question Web based survey (SurveyMonkey.com) was distributed to recent Nuclear Medicine residency graduates via the Nuclear Medicine Residency Program Directors list-serve. The survey was also posted on the SNM Young Professionals Committee Web site. Questions included prior training, current employment, job search criteria, targeted employers, and assets and limitations in obtaining a job. Results: 72 people responded to the survey. 14 did not adequately complete the survey and were not included in the analysis. 20 surveys were incomplete but adequate for analysis. Of the 58 respondents included in the analysis, 38 were board certified in Nuclear Medicine, and 12(32%) of these had additional certifications, most commonly in radiology. 29 of 40 individuals who completed Nuclear Medicine training within the past 2 years are employed, 11 are unemployed. Individuals who are board certified in Nuclear Medicine are more likely to be employed than those who are not board certified (p 2 years in 16%. The top 3 resources used to inquire about job offerings were personal contacts, word of mouth, and the SNM Job Bank. Most (83%) stated restricting their job search geographically was not a factor in receiving job interviews/offers. Skills which contributed most to receipt of a job offer were knowledge of general Nuclear Medicine and PET/CT training. The most cited reason for denial of a private practice job was the inability to share general radiology reading and call with the group. Conclusions: This study should be interpreted with caution due to the potential bias in the method of survey distribution and the limited quantity and quality of responses. Our results suggest that most recently board certified Nuclear Medicine physicians have been successful in finding employment within a reasonable time frame (
Frederick D. Grant - One of the best experts on this subject based on the ideXlab platform.
-
Nuclear Medicine and Radiation Protection
Journal of Radiology Nursing, 2016Co-Authors: Frederic H. Fahey, Alison Goodkind, S. Ted Treves, Frederick D. GrantAbstract:Abstract Nuclear Medicine and molecular imaging procedures play an important role in the diagnosis, assessment, and treatment of many diseases. These include diseases of the heart, skeleton, brain, and kidneys as well as applications in oncology. The following article discusses various Nuclear Medicine diagnostic and therapeutic applications, and the technology behind them. Finally, radiation safety in the context of Nuclear Medicine will be discussed. It is important that all members of the Nuclear Medicine team are equipped to provide an appropriate discussion of the benefits and risks of Nuclear Medicine to our patients and their families.
-
General Aspects of Pediatric Nuclear Medicine
Pediatric Nuclear Medicine and Molecular Imaging, 2014Co-Authors: S. Ted Treves, Frederick D. GrantAbstract:Pediatric Nuclear Medicine is a very interesting, dynamic, and exciting field. Nuclear Medicine contributes to the diagnosis of many diseases in children. Well-established procedures reveal physiological processes in vivo, permit early detection of disease, help patient management and therapeutic decisions, and provide an important tool to follow the success of therapy or to assess progression of disease. One of the reasons that Nuclear Medicine in pediatric patients remains successful is that Nuclear Medicine studies provide information about the patient’s condition that cannot be obtained easily (or sometimes at all) with other diagnostic methods. Some Nuclear Medicine procedures require pharmacologic interventions. Examples include the administration of furosemide, acetazolamide, phenobarbital, cholecystokinin analog, and dobutamine. Pediatric patients, with their wide range of body size, physical and psychological developmental changes, and medical disorders, present unique challenges. Patients in pediatric Nuclear Medicine range in weight from premature infants to young adults reaching adult weight. It has been said that children are not small adults, and even in Nuclear Medicine “one size does not fit all.”
James S Adelstein - One of the best experts on this subject based on the ideXlab platform.
-
minimizing and communicating radiation risk in pediatric Nuclear Medicine
The Journal of Nuclear Medicine, 2012Co-Authors: Frederic H. Fahey, Ted S Treves, James S AdelsteinAbstract:The value of pediatric Nuclear Medicine is well established. Pediatric patients are referred to Nuclear Medicine from nearly all pediatric specialties including urology, oncology, cardiology, gastroenterology, and orthopedics. Radiation exposure is associated with a potential, small, risk of inducing cancer in the patient later in life and is higher in younger patients. Recently, there has been enhanced interest in exposure to radiation from medical imaging. Thus, it is incumbent on practitioners of pediatric Nuclear Medicine to have an understanding of dosimetry and radiation risk to communicate effectively with their patients and their families. This article reviews radiation dosimetry for radiopharmaceuticals and also CT given the recent proliferation of PET/CT and SPECT/CT. It also describes the scientific basis for radiation risk estimation in the context of pediatric Nuclear Medicine. Approaches for effective communication of risk to patients' families are discussed. Lastly, radiation dose reduction in pediatric Nuclear Medicine is explicated.
